SuperworthOrganon market cap OGN
Share price times shares outstanding: what the whole company sells for, since 2021.
- Today, Oct 23, 2026
- $3.6B
- Highest close in our data
- $9.9B
- May 2022
Organon is worth $3.6B at the close on Oct 23, 2026, at $13.75 a share.
That is up 52% over the last year and down 61% over five years.
Its highest close in our data was $9.9B in May 2022.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $3.6B | $1.5B | $3.6B | +93% |
| 2025 | $1.9B | $1.8B | $4.1B | −52% |
| 2024 | $3.9B | $3.7B | $5.8B | +5% |
| 2023 | $3.7B | $2.8B | $8.2B | −48% |
| 2022 | $7.1B | $5.9B | $9.9B | −8% |
| 2021 | $7.7B | $7.3B | $9.3B | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest Organon's size, closest first, today.
| Company | Market cap |
|---|---|
| OGNOrganon | $3.6B |
| LQDALiquidia | $3.8B |
| ARQTArcutis Biotherapeutics | $3.9B |
| INDVIndivior Pharmaceuticals | $4.1B |
| NRIXNurix Therapeutics | $2.8B |
| PBHPrestige Consumer Healthcare | $2.3B |
| KNSAKiniksa Pharmaceuticals International | $6B |
| LGNDLigand Pharmaceuticals | $6.1B |
| HRMYHarmony Biosciences | $2.1B |
| AMRXAmneal Pharmaceuticals | $6.5B |
| ALKSAlkermes plc. | $7.3B |
| Peer median | $4B |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Organon
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.